Respirology

Previous issue Volume 22 Issue 7
October 2017
Next issue
Index Submit
an article
About
Respirology
Read this
issue's articles
EDITORIALS
1239Where to start when treating COPD?
Peter M.A. Calverley
10.1111/resp.13126
1241Unravelling the impact of early life exposures on lung structure and function in the developmental origins of asthma
Christopher D. Pascoe
10.1111/resp.13098
1243Partitioning strength exercises as an alternative training modality for patients with COPD
Anouk W. Vaes
10.1111/resp.13087
1245Real-time visual-feedback mask-fitting during non-invasive ventilation: A 'technological' gain over 'human' sensing?
Antonello Nicolini, Raffaele Scala and Maurizio A. Cavalleri
10.1111/resp.13101
1247Mortality prediction in community-acquired pneumonia: Simplifying reliable tools may be worth it
Diego Lopez-Mendoza
10.1111/resp.13099
1249Connecting insomnia, sleep apnoea and depression
Michael A. Grandner and Atul Malhotra
10.1111/resp.13090
1251Dissecting the benefits of long-term non-invasive ventilation in patients with distinct neuromuscular disorders
Matthias Boentert
10.1111/resp.13103
INVITED REVIEW SERIES
Respiratory Sleep Disorders
1253Reviewing the relationship between OSA and cognition: Where do we go from here?
Romola S. Bucks, Michelle Olaithe, Ivana Rosenzweig and Mary J. Morrell
10.1111/resp.13140
Seeking Innovative Solutions in Severe Asthma
1262Multidimensional assessment of severe asthma: A systematic review and meta-analysis
Vanessa L. Clark, Peter G. Gibson, Grayson Genn, Sarah A. Hiles, Ian D. Pavord and Vanessa M. McDonald
10.1111/resp.13134
Respiratory Infections in the Asia-Pacific Region
1276Pneumonia in the developing world: Characteristic features and approach to management
Stephen J. Aston
10.1111/resp.13112
1288The respiratory threat posed by multidrug resistant Gram-negative bacteria
Ana Rodrigo-Troyano and Oriol Sibila
10.1111/resp.13115
1300A clinical approach to the threat of emerging influenza viruses in the Asia-Pacific region
David S.C. Hui, Nelson Lee and Paul K.S. Chan
10.1111/resp.13114
SYSTEMATIC REVIEW
1313Long-acting beta2-agonists versus long-acting muscarinic antagonists in patients with stable COPD: A systematic review and meta-analysis of randomized controlled trials
Wang-Chun Chen, Chi-Hsien Huang, Chau-Chyun Sheu, Inn-Wen Chong, Kuo-An Chu, Yung-Che Chen, Jong-Rung Tsai, Cheng-Hung Lee and Yu-Feng Wei
10.1111/resp.13100
ORIGINAL ARTICLES
Asthma and Allergy
1320Lung function in relation to farm dwelling and farming activities in rural dwelling children
Lakshmi Balakrishnan, Donna Rennie, James Dosman, Punam Pahwa, Chandima Karunanayake, Louise Hagel and Joshua Lawson
10.1111/resp.13097

We investigated pulmonary function in a rural paediatric Canadian population of farm and non-farm dwelling children. Overall, lung function in both populations was excellent with slightly better lung function in children living on farms.

1329Increased heterogeneity of airway calibre in adult rats after hypoxia-induced intrauterine growth restriction
Kimberley C.W. Wang, Jude S. Morton, Sandra T. Davidge, Alexander N. Larcombe, Alan L. James, Graham M. Donovan and Peter B. Noble
10.1111/resp.13071

Intrauterine growth-restricted individuals have an increased risk of asthma development. The reason for this association is not known. This study used a rat model of intrauterine growth restriction to show persisting structural changes to the airway that has potential implications for bronchoconstriction and disease susceptibility.

COPD
1336Does limb partitioning and positioning affect acute cardiorespiratory responses during strength exercises in patients with COPD?
Priscila Robles, Tamara Araujo, Dina Brooks, Karl Zabjek, Tania Janaudis-Ferreira, Susan Marzolini, Roger Goldstein and Sunita Mathur
10.1111/resp.13056

Acute cardiorespiratory responses to short bouts of strength exercises may not be affected by the number of limbs engaged; however, responses are greater when arm exercises are performed overhead. This information can assist in the design of upper extremity strength training programmes for patients with COPD.

Critical Care
1343Randomized crossover trial of a pressure sensing visual feedback system to improve mask fitting in noninvasive ventilation
Anne-Kathrin Brill, Mohammad Moghal, Mary J. Morrell and Anita K. Simonds
10.1111/resp.13074

In a simulated mask-fitting scenario for noninvasive ventilation, real-time visual feedback on pressure exerted over the nasal bridge led to a significantly lower pressure on the face without increase in air leak. The feedback technology improved mask-fitting skills of trained and untrained healthcare professionals.

Environmental and Occupational Lung Disease
1350Histological variability and consequences in chronic bird-related hypersensitivity pneumonitis
Junichi Ochi, Yoshio Ohtani, Tamiko Takemura, Takumi Akashi, Tomoya Tateishi, Yasunari Miyazaki, Naohiko Inase and Yasuyuki Yoshizawa
10.1111/resp.13070

Spatial histopathological variability and temporal changes of pathology in chronic bird-related hypersensitivity pneumonitis (BRHP) was evaluated. Wide variability in histopathological features was characteristic. Our case series suggests that initial fibrotic nonspecific patterns can later change to bronchiolocentric interstitial pneumonia patterns or usual interstitial pneumonia patterns at autopsy.

Interstitial Lung Disease
1357Direct hemoperfusion with polymyxin B-immobilized fibre treatment for acute exacerbation of interstitial pneumonia
Haruhiko Furusawa, Makiko Sugiura, Chieko Mitaka and Naohiko Inase
10.1111/resp.13054

We evaluated the effectiveness and safety of polymyxin B-immobilized fibre column-direct hemoperfusion (PMX-DHP) treatment for patients with acute exacerbation (AE) of interstitial pneumonia. The results showed that PMX-DHP may improve the prognosis of patients with AE when inducted in the early phase of the exacerbation, especially in patients with dermatomyositis.

1363High-dose prednisolone after intravenous methylprednisolone improves prognosis of acute exacerbation in idiopathic interstitial pneumonias
Toru Arai, Kazunobu Tachibana, Chikatoshi Sugimoto, Yasushi Inoue, Sayoko Tokura, Tomohisa Okuma, Masanori Akira, Masanori Kitaichi, Seiji Hayashi and Yoshikazu Inoue
10.1111/resp.13065

Multivariate Cox proportional hazard regression analysis revealed that an initial prednisolone (PSL) dose ≥ 0.6 mg/kg is a significant factor for a good prognosis in acute exacerbation of idiopathic interstitial pneumonias without management with positive pressure ventilation. Hence, such doses of PSL may be recommended when commencing treatment.

1371
Serum YKL-40 is a reliable biomarker for pulmonary alveolar proteinosis
Francesco Bonella, Xiaoping Long, Xuan He, Shinichiro Ohshimo, Matthias Griese, Josune Guzman and Ulrich Costabel
10.1111/resp.13082

We evaluated the role of YKL-40, a chitinase-like protein produced by macrophages and epithelial cells, as a biomarker to assess disease activity and outcome in pulmonary alveolar proteinosis (PAP). YKL-40 was elevated in serum and bronchoalveolar lavage fluid (BALF) of PAP patients, and correlated with respiratory impairment and disease outcome.

Lung Cancer
1379Modified GAP index for prediction of acute exacerbation of idiopathic pulmonary fibrosis in non-small cell lung cancer
Haruki Kobayashi, Shota Omori, Kazuhisa Nakashima, Kazushige Wakuda, Akira Ono, Hirotsugu Kenmotsu, Tateaki Naito, Haruyasu Murakami, Masahiro Endo and Toshiaki Takahashi
10.1111/resp.13075

The aim of this study was to estimate the rate of incidence of IPF (idiopathic pulmonary fibrosis)-AE (acute exacerbation) and its prognosis in patients with non-small cell lung cancer (NSCLC) and IPF. The present study suggests that modified gender, age and physiology mGAP index score and stage may predict IPF-AE and its prognosis in patients with NSCLC and IPF.

Pulmonary Vascular Disease
1386
Clinical characteristics and survival of systemic sclerosis patients with pulmonary hypertension and elevated wedge pressure: Observations from the PHAROS cohort
Matthew R. Lammi, Lesley A. Saketkoo, Jessica K. Gordon, Paula Lauto, Karen Fagan, Virginia D. Steen and on behalf of the PHAROS Investigators
10.1111/resp.13067

We analysed data for 59 patients with systemic sclerosis-pulmonary hypertension (PH) and an elevated wedge pressure and found that there was no difference in clinical outcomes between those with post-capillary PH and combined pre- and post-capillary PH. The 6-min walk distance was a predictor of death in this group.

1393CT-determined pulmonary artery to aorta ratio as a predictor of elevated pulmonary artery pressure and survival in idiopathic pulmonary fibrosis
Mitsuaki Yagi, Hiroyuki Taniguchi, Yasuhiro Kondoh, Masahiko Ando, Tomoki Kimura, Kensuke Kataoka, Taiki Furukawa, Atsushi Suzuki, Takeshi Johkoh and Yoshinori Hasegawa
10.1111/resp.13066

In idiopathic pulmonary fibrosis (IPF), the ratio of the diameter of the pulmonary artery to the aorta (PA:A) was significantly correlated with mean pulmonary artery pressure (mPAP). In multivariate analysis, the PA:A, 6-min walk distance (6MWD) and diffusion capacity for carbon monoxide (DLCO) % predicted were independent predictors of mPAP. Moreover, a PA:A > 0.9 was associated with a worse prognosis.

Respiratory Infections
1400Functional status and mortality prediction in community-acquired pneumonia
Kyeongman Jeon, Hongseok Yoo, Byeong-Ho Jeong, Hye Yun Park, Won-Jung Koh, Gee Young Suh and Eliseo Guallar
10.1111/resp.13072

Premorbid functional status (FS) was independently associated with mortality in unselected patients with community-acquired pneumonia. In addition, adding premorbid FS to the CRB-65 (confusion, respiratory rate, blood pressure and age 65) score showed a significantly and clinically relevant improvement in the predictive ability of CRB-65.

Sleep and Ventilation
1407Co-morbid OSA and insomnia increases depression prevalence and severity in men
Carol J. Lang, Sarah L. Appleton, Andrew Vakulin, R. Doug McEvoy, Gary A. Wittert, Sean A. Martin, Peter G. Catcheside, Nicholas A. Antic, Leon Lack and Robert J. Adams
10.1111/resp.13064

We investigated the prevalence and clinical profile of previously undiagnosed co-morbid obstructive sleep apnoea (OSA) and insomnia symptoms (COMISA) in men. Men with COMISA have a higher prevalence, and severity, of depressive symptoms than men with OSA or insomnia symptoms alone. This has implications when planning how to identify and treat COMISA in the community.

1416Effects of 1-month withdrawal of ventilatory support in hypercapnic myotonic dystrophy type 1
Fergal J. O'Donoghue, Jean-Christian Borel, Yves Dauvilliers, Patrick Levy, Renaud Tamisier and Jean-Louis Pépin
10.1111/resp.13068

Withdrawal of non-invasive ventilatory support in myotonic dystrophy patients with chronic hypercapnia produced no change in quality of life (QOL) nor somnolence. Small deteriorations were seen in nocturnal oxygenation and daytime CO2 , but without changes in respiratory drive nor lung function. This suggests that the benefits of ventilation support in this group are uncertain.

Tuberculosis
1423Tuberculosis in China: A longitudinal predictive model of the general population and recommendations for achieving WHO goals
Kaijin Xu, Cheng Ding, Connor J. Mangan, Yiping Li, Jingjing Ren, Shigui Yang, Bing Wang, Bing Ruan, Jifang Sheng and Lanjuan Li
10.1111/resp.13078

We used an eight-state Markov model to predict the tuberculosis (TB) epidemic over 50 years among the general population in China, and we determined the influencing factors and suggested a specific 90-90-90 strategy for TB. Under this strategy, the prevalence would be 1.77 cases per 100,000 population within 50 years.

POSITION STATEMENTS
1430Spirometry training courses: Content, delivery and assessment - a position statement from the Australian and New Zealand Society of Respiratory Science
Maureen P. Swanney, Christopher A. O'Dea, Emily R. Ingram, Leanne T. Rodwell, Brigitte M. Borg and for the ANZSRS Spirometry Training Course Working Group
10.1111/resp.13133
1436Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia
Helen E. Jo, Lauren K. Troy, Gregory Keir, Daniel C. Chambers, Anne Holland, Nicole Goh, Margaret Wilsher, Sally de Boer, Yuben Moodley, Christopher Grainge, Helen Whitford, Sally Chapman, Paul N. Reynolds, Ian Glaspole, David Beatson, Leonie Jones, Peter Hopkins and Tamera J. Corte
10.1111/resp.13146
1459The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia
Jyotika D. Prasad, Annabelle Mahar, Jane Bleasel, Samantha J. Ellis, Daniel C. Chambers, Fiona Lake, Peter M.A. Hopkins, Tamera J. Corte, Heather Allan and Ian N. Glaspole
10.1111/resp.13163
CORRESPONDENCE
1473Should resistance training be targeted to a specific subgroup of patients with non-small cell lung cancer?
Vinicius Cavalheri, Daniel A. Galvão, Leon M. Straker and Kylie Hill
10.1111/resp.13130
1474Should resistance training be targeted to a specific subgroup of patients with non-small cell lung cancer? – Reply
Chris Burtin, Frits M.E. Franssen and Martijn A. Spruit
10.1111/resp.13129

Index

2024 MayVol. 29 Issue 5
2024 AprVol. 29 Issue 4
2024 MarVol. 29 Issue 3
2023 MarVol. 29 Supplement 1
ANZSRS/TSANZ Annual Scientific Meeting 2024
2024 FebVol. 29 Issue 2
2024 JanVol. 29 Issue 1
2023 DecVol. 28 Issue 12
2023 NovVol. 28 Issue 11
2023 NovVol. 28 Supplement 4
APSR 2023 Congress Abstracts
2023 OctVol. 28 Issue 10
2023 SepVol. 28 Issue 9
2023 AugVol. 28 Issue 8
2023 JulVol. 28 Issue 7
2023 JunVol. 28 Issue 6
2023 MayVol. 28 Issue 5
2023 AprVol. 28 Issue 4
2023 MarVol. 28 Issue 3
2023 MarVol. 28 Supplement 3
Australian Lung Cancer Conference 2023
2023 MarVol. 28 Supplement 2
ANZSRS/TSANZ Annual Scientific Meeting 2023
2023 FebVol. 28 Issue 2
2023 FebVol. 28 Supplement 1
APSR 2022 Congress Abstracts
2023 JanVol. 28 Issue 1
2022 DecVol. 27 Issue 12
2022 NovVol. 27 Issue 11
2022 OctVol. 27 Issue 10
2022 SepWorld Lung Day 2022
2022 SepVol. 27 Issue 9
2022 AugVol. 27 Issue 8
2022 JulVol. 27 Issue 7
2022 JunVol. 27 Issue 6
Special Issue: Occupational Lung Health
2022 MayVol. 27 Issue 5
2022 AprVol. 27 Issue 4
2022 MarVol. 27 Issue 3
2022 MarVol. 27 Issue s1
ANZSRS and TSANZ abstracts
2022 FebVol. 27 Issue 2
2022 JanVol. 27 Issue 1
2021 DecVol. 26 Issue 12
2021 NovVol. 26 Issue 11
2021 NovVol. 26 Supplement 3
APSR Congress Abstracts
2021 OctVol. 26 Issue 10
2021 SepVol. 26 Issue 9
2021 AugVol. 26 Issue 8
2021 JulVol. 26 Issue 7
2021 JunVol. 26 Issue 6
2021 MayVol. 26 Issue 5
2021 AprVol. 26 Issue 4
2021 AprVol. 26 Issue s2
ANZSRS and TSANZ abstracts
2021 MarVol. 26 Issue 3
2021 FebVol. 26 Issue 2
2021 JanVol. 26 Issue s1
Supplement: APSR Assembly Virtual Meetings
2021 JanVol. 26 Issue 1
2020 DecVol. 25 Issue 12
2020 NovVol. 25 Issue 11
2020 NovVol. 25 Issue s2
Essential update in lung cancer medicine
2020 OctVol. 25 Issue 10
2020 SepVol. 25 Issue 9
Special issue: Interventional Pulmonoogy pearls
2020 AugVol. 25 Issue 8
2020 JulVol. 25 Issue 7
2020 JunVol. 25 Issue 6
2020 JunVol. 25 Supplement 1
ANZSRS and TSANZ abstracts
2020 MayVol. 25 Issue 5
2020 AprVol. 25 Issue 4
2020 MarVol. 25 Issue 3
2020 FebVol. 25 Issue 2
2020 JanVol. 25 Issue 1
2019 DecVol. 24 Issue 12
2019 NovVol. 24 Issue 11
2019 NovVol. 24 Supplement 2
APSR Congress Abstracts
2019 OctVol. 24 Issue 10
2019 SepVol. 24 Issue 9
2019 AugVol. 24 Issue 8
2019 JulVol. 24 Issue 7
2019 JunVol. 24 Issue 6
2019 MayVol. 24 Issue 5
2019 AprVol. 24 Issue 4
2019 MarVol. 24 Issue 3
2019 MarVol. 24 Supplement 1
ANZSRS and TSANZ abstracts
2019 FebVol. 24 Issue 2
2019 JanVol. 24 Issue 1
2018 DecVol. 23 Issue 12
2018 NovVol. 23 Supplement 2
APSR Congress Abstracts
2018 NovVol. 23 Issue 11
2018 OctVol. 23 Issue 10
2018 SepVol. 23 Issue 9
2018 AugVol. 23 Issue 8
2018 JulVol. 23 Issue 7
2018 JunVol. 23 Issue 6
2018 MayVol. 23 Issue 5
2018 AprVol. 23 Issue 4
2018 MarVol. 23 Supplement 1
ANZSRS and TSANZ abstracts
2018 MarVol. 23 Issue 3
2018 FebVol. 23 Issue 2
2018 JanVol. 23 Issue 1
2017 NovVol. 22 Supplement 3
APSR Congress Abstracts
2017 NovVol. 22 Issue 8
2017 OctVol. 22 Issue 7
2017 AugVol. 22 Issue 6
2017 JulyVol. 22 Issue 5
2017 MayVol. 22 Issue 4
2017 AprVol. 22 Issue 3
2017 MarVol. 22 Supplement 2
ANZSRS and TSANZ abstracts
2017 MarVol. 22 Supplement 1
Airway Vista abstracts
2017 FebVol. 22 Issue 2
2017 JanVol. 22 Issue 1
2016 NovVol. 21 Supplement 3
APSR Congress Abstracts
2016 NovVol. 21 Issue 8
2016 OctVol. 21 Issue 7
2016 AugVol. 21 Issue 6
2016 JulVol. 21 Issue 5
2016 MayVol. 21 Issue 4
2016 AprVol. 21 Supplement 2
ANZSRS and TSANZ abstracts
2016 AprVol. 21 Issue 3
2016 MarVol. 21 Supplement 1
Airway Vista abstracts
2016 FebVol. 21 Issue 2
2016 JanVol. 21 Issue 1
2015 DecVol. 20 Supplement 3
APSR Congress Abstracts
2015 NovVol. 20 Issue 8
2015 OctVol. 20 Issue 7
2015 AugVol. 20 Issue 6
2015 JulVol. 20 Issue 5
2015 MayVol. 20 Issue 4
2015 AprVol. 20 Issue 3
2015 MarVol. 20 Supplement 2
ANZSRS and TSANZ abstracts
2015 MarVol. 20 Supplement 1
Airway Vista abstracts
2015 FebVol. 20 Issue 2
2015 JanVol. 20 Issue 1
2014 NovVol. 19 Issue 8
2014 NovVol. 19 Supplement 3
APSR Congress Abstracts
2014 OctVol. 19 Issue 7
2014 AugVol. 19 Issue 6
2014 JulVol. 19 Issue 5
2014 MayVol. 19 Issue 4
2014 AprVol. 19 Issue 3
2014 AprVol. 19 Supplement 2
ANZSRS and TSANZ abstracts
2014 MarVol. 19 Supplement 1
Airway Inflammation
2014 FebVol. 19 Issue 2
2014 JanVol. 19 Issue 1
2013 NovVol. 18 Issue 8
2013 OctVol. 18 Supplement 4
APSR Congress Abstracts
2013 NovVol. 18 Supplement 3
Airway Inflammation
2013 OctVol. 18 Issue 7
2013 AugVol. 18 Issue 6
2013 JulVol. 18 Issue 5
2013 MayVol. 18 Issue 4
2013 AprVol. 18 Issue 3
2013 AprVol. 18 Supplement 2
ANZSRS and TSANZ abstracts
2013 AprVol. 18 Supplement 1
Airway Vista abstracts
2013 FebVol. 18 Issue 2
2013 JanVol. 18 Issue 1
2012 DecVol. 17 Supplement 2
APSR Congress Abstracts
2012 NovVol. 17 Issue 8
2012 OctVol. 17 Issue 7
2012 AugVol. 17 Issue 6
2012 JulVol. 17 Issue 5
2012 MayVol. 17 Issue 4
2012 AprVol. 17 Issue 3
2012 AprVol. 17 Supplement 1
ANZSRS and TSANZ abstracts
2012 FebVol. 17 Issue 2
2012 JanVol. 17 Issue 1
2011 NovVol. 16 Issue 8
2011 NovVol. 16 Supplement 2
APSR Congress Abstracts
2011 OctVol. 16 Issue 7
2011 AugVol. 16 Issue 6
2011 JulVol. 16 Issue 5
2011 MayVol. 16 Issue 4
2011 AprVol. 16 Issue 3
2011 AprVol. 16 Supplement 1
ANZSRS and TSANZ abstracts
2011 FebVol. 16 Issue 2
2011 JanVol. 16 Issue 1
2010 NovVol. 15 Supplement 2
APSR Congress Abstracts
2010 NovVol. 15 Issue 8
2010 OctVol. 15 Issue 7
2010 AugVol. 15 Issue 6
2010 JulVol. 15 Issue 5
2010 MayVol. 15 Issue 4
2010 AprVol. 15 Issue 3
2010 MarVol. 15 Supplement 1
ANZSRS and TSANZ abstracts
2010 FebVol. 15 Issue 2
2010 JanVol. 15 Issue 1
2009 NovVol. 14 Issue 8
2009 NovVol. 14 Supplement 3
APSR Congress Abstracts
2009 OctVol. 14 Supplement 2
Guidelines: Hospital-Acquired Pneumonia
2009 SepVol. 14 Issue 7
2009 Vol. 14 Issue 6
2009 JulVol. 14 Issue 5
2009 MayVol. 14 Issue 4
2009 AprVol. 14 Issue 3
2009 AprVol. 14 Supplement 1
ANZSRS and TSANZ abstracts
2009 MarVol. 14 Issue 2
2009 JanVol. 14 Issue 1
2008 NovVol. 13 Issue 7
2008 NovVol. 13 Supplement 5
APSR Congress Abstracts
2008 NovVol. 13 Supplement 4
Lung Disease
2008 SepVol. 13 Issue 6
2008 SepVol. 13 Supplement 3
ESAP: TB
2008 JulVol. 13 Issue 5
2008 JunVol. 13 Issue 4
2008 MayVol. 13 Issue 3
2008 AprVol. 13 Supplement 2
ANZSRS and TSANZ Abstracts
2008 MarVol. 13 Supplement 1
ESAP Abstracts
2008 MarVol. 13 Issue 2
2008 JanVol. 13 Issue 1
2007 NovVol. 12 Supplement 4
APSR Congress Abstracts
2007 NovVol. 12 Supplement 3
Asthma
2007 NovVol. 12 Issue 6
2007 SepVol. 12 Issue 5
2007 JulVol. 12 Issue 4
2007 MayVol. 12 Supplement 2
ESAP Abstracts
2007 MayVol. 12 Issue 3
2007 MarVol. 12 Supplement 1
ANZSRS and TSANZ Abstracts
2007 MarVol. 12 Issue 2
2007 JanVol. 12 Issue 1
2006 NovVol. 11 Supplement 5
APSR Congress Abstracts
2006 NovVol. 11 Issue 6
2006 SepVol. 11 Supplement 4
Guidelines: Cough
2006 SepVol. 11 Supplement 3
Guidelines: Respiratory Infections
2006 SepVol. 11 Issue 5
2006 JulVol. 11 Issue 4
2006 MayVol. 11 Issue 3
2006 MarVol. 11 Supplement 2
ANZSRS and TSANZ abstracts
2006 MarVol. 11 Issue 2
2006 JanVol. 11 Supplement 1
Surfactant Molecular Pathophysiology
2006 JanVol. 11 Issue 1
2005 NovVol. 10 Supplement 3
APSR Congress Abstracts
2005 NovVol. 10 Supplement 2
Respiratory function tests
2005 NovVol. 10 Issue 5
2005 SepVol. 10 Issue 4
2005 JunVol. 10 Issue 3
2005 MarVol. 10 Supplement 1
ANZSRS and TSANZ abstracts
2005 MarVol. 10 Issue 2
2005 JanVol. 10 Issue 1
2004 DecVol. 9 Supplement 3
APSR Congress Abstracts
2004 NovVol. 9 Issue 4
2004 AugVol. 9 Issue 3
2004 JunVol. 9 Issue 2
2004 MarVol. 9 Supplement 2
APSR Congress Abstracts
2004 MarVol. 9 Supplement 1
Guidelines: Hospital-Acquired Pneumonia
2004 MarVol. 9 Issue 1
2003 DecVol. 8 Issue 4
2003 NovVol. 8 Supplement 1
SARS
2003 SepVol. 8 Issue 3
2003 JunVol. 8 Issue 2
2003 AprVol. 8 Supplement 2
APSR Congress Abstracts
2003 MarVol. 8 Issue 1
2002 DecVol. 7 Issue 4
2002 SepVol. 7 Issue 3
2002 JunVol. 7 Issue 2
2002 MarVol. 7 Supplement 1
APSR Congress Abstracts
2002 MarVol. 7 Issue 1
2001 DecVol. 6 Issue 4
2001 SepVol. 6 Issue 3
2001 JunVol. 6 Supplement 2
Chronic Obstructive Lung Diseases
2001 JunVol. 6 Issue 2
2001 MarVol. 6 Issue 1
2000 DecVol. 5 Issue 4
2000 SepVol. 5 Issue 3
2000 JunVol. 5 Issue 2
2000 JunVol. 05 Supplement 2
TSANZ abstracts
2000 AprVol. 05 Supplement 1
TSANZ abstracts
2000 MarVol. 5 Issue 1
1999 DecVol. 4 Issue 4
1999 SepVol. 4 Issue 3
1999 JunVol. 4 Issue 2
1999 AprVol. 04 Supplement 1
TSANZ abstracts
1999 JanVol. 4 Issue 1
1998 DecVol. 3 Issue 4
1998 SepVol. 3 Issue 3
1998 JunVol. 3 Issue 2
1998 MarVol. 3 Issue 1
1997 DecVol. 2 Issue 4
1997 SepVol. 2 Issue 3
1997 JunVol. 2 Issue 2
1997 MarVol. 2 Issue 1
1996 DecVol. 1 Issue 4
1996 SepVol. 1 Issue 3
1996 JunVol. 1 Issue 2
1996 MarVol. 1 Issue 1